Search

eISSN: 2717-1884

Submit Your Paper Instructions for Authors Journal Information Aims and Scope Editorial Board Publication Ethics Editorial Policies Open Access Indexing Info Peer Review Archive

Indexing Information

Follower of

December 2022, Vol 3, No. 2

Publisher

Hamadan University of Medical Sciences

Director-in-Charge:

Prof. Katayoun Derakhshandeh

Editor-in-Chief:

Dr. Reza Mahjoub

Original Article

1. Comparison of the Total Side Effects of Injectable Disease-Modifying Drugs for the First-line Treatment of Relapsing-Remitting Multiple Sclerosis

Masoud Ghiasian , Seyedeh Anis Rashidizad, Mojdeh Mohammadi, Younes Mohammadi, Sara Ataei*

Avicenna J Pharm Res. 2022;3(1): 32-36. doi: 10.34172/ajpr.2022.1065

Article

PDF

XML

Cited By:

0